Inhibition of p53 inhibitors: progress, challenges and perspectivesGema Sanz, Galina Selivanova|Journal of Molecular Cell Biology|2019Cited by 137
Pharmacological activation of p53 triggers anticancer innate immune response through induction of ULBP2Hai Li, Galina Selivanova, Cinzia Garofalo et al.|Cell Cycle|2011Cited by 118
Mutant p53 gain of function mediates cancer immune escape that is counteracted by APR-246Xiaolei Zhou, Galina Selivanova|British Journal of Cancer|2022Cited by 23